LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 67 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,457,125 | +34.7% | 2,900,538 | +6.8% | 0.13% | +18.6% |
Q2 2023 | $8,503,312 | -3.2% | 2,716,713 | +40.1% | 0.11% | -7.4% |
Q1 2023 | $8,782,864 | +44.1% | 1,938,822 | +31.3% | 0.12% | +28.4% |
Q4 2022 | $6,096,805 | +36.8% | 1,476,224 | -46.9% | 0.10% | +90.0% |
Q3 2022 | $4,456,452 | +462.7% | 2,782,672 | +589.0% | 0.05% | +212.5% |
Q2 2022 | $792,000 | -54.0% | 403,890 | -4.9% | 0.02% | -23.8% |
Q1 2022 | $1,720,000 | -32.4% | 424,599 | +80.0% | 0.02% | +16.7% |
Q4 2021 | $2,545,000 | +177.2% | 235,835 | +196.1% | 0.02% | +125.0% |
Q3 2021 | $918,000 | -61.8% | 79,656 | -67.4% | 0.01% | -63.6% |
Q2 2021 | $2,403,000 | -28.3% | 244,675 | +6.7% | 0.02% | -42.1% |
Q1 2021 | $3,350,000 | +27.1% | 229,301 | +86.3% | 0.04% | +65.2% |
Q4 2020 | $2,636,000 | +234.1% | 123,107 | +136.7% | 0.02% | +43.8% |
Q3 2020 | $789,000 | – | 52,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 2,746,265 | $12,440,580 | 3.30% |
Opaleye Management Inc. | 1,401,000 | $6,346,530 | 1.90% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $76,744,347 | 1.71% |
GREAT POINT PARTNERS LLC | 900,000 | $4,077,000 | 0.80% |
DAFNA Capital Management LLC | 236,873 | $1,073,035 | 0.32% |
Perceptive Advisors | 2,280,709 | $10,331,612 | 0.30% |
Atlas Venture Advisors, Inc. | 292,184 | $1,323,594 | 0.28% |
MANGROVE PARTNERS IM, LLC | 805,815 | $3,650,342 | 0.24% |
Verition Fund Management LLC | 1,938,822 | $8,782,864 | 0.12% |
Woodline Partners LP | 1,681,913 | $7,619,066 | 0.10% |